UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 26, 2024

Accession Number:	0001539497-24-000584
Submission Type:	POS AM
CIK: 0001358403 Company Name: BELLICUM PHARMACEUTICALS, INC File Number: 333-232771